Nippon Chemiphar Co., Ltd.
4539.T
Price:
$1537
Market Cap:
$5.55B
Nippon Chemiphar Co., Ltd., together with its subsidiaries, manufactures, markets, imports, exports, and sells, ethical pharmaceuticals and diagnostic agents in Japan and internationally. It offers diagnostic products, such as IgE NC, a diagnostic kit that provides results and reveals total IgE levels, as well as 57 individual allergen reagents; and DP3000, a device for allergen-specific IgE measurements. The company also develops NC-2400, a PPAR-delta agonist; NC-2500, a novel advanced xanthine oxidoreductase inhibitor for the treatment of hyperuricemia/gout; and NC-2600, a P2X4 receptor antagonist for the treatment of neuropathic pain. In addition, it develops NC-2700, a novel urate transp...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2001-01-01
Stock Exchange
JPX
Ticker
4539.T
PE Ratio
[11.04]
ROE
[2.10%]
Current Ratio
[2.36]
Dividend Yield
[3.25%]
Enterprise Value
[15.09B]
Dividend History
The ROE as of December 2025 (TTM) for Nippon Chemiphar Co., Ltd. (4539.T) is 2.10%
According to Nippon Chemiphar Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 2.10%. This represents a change of 307.97% compared to the average of 0.52% of the last 4 quarters.
Nippon Chemiphar Co., Ltd. (4539.T) Historical ROE (quarterly & annually)
How has 4539.T ROE performed in the past?
The mean historical ROE of Nippon Chemiphar Co., Ltd. over the last ten years is 4.71%. The current 2.10% ROE has changed -55.29% with respect to the historical average. Over the past ten years (40 quarters), 4539.T's ROE was at its highest in in the December 2016 quarter at 5.08%. The ROE was at its lowest in in the March 2023 quarter at -1.86%.
Average
4.71%
Median
3.27%
Minimum
-0.98%
Maximum
12.22%
Nippon Chemiphar Co., Ltd. (4539.T) ROE by Quarter and Year
Discovering the peaks and valleys of Nippon Chemiphar Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 37.68%
Maximum Annual ROE = 12.22%
Minimum Annual Increase = -257.31%
Minimum Annual ROE = -0.98%
| Year | ROE | Change |
|---|---|---|
| 2025 | 1.53% | -257.31% |
| 2024 | -0.98% | -153.31% |
| 2023 | 1.83% | -51.66% |
| 2022 | 3.78% | 37.68% |
| 2021 | 2.75% | 9.61% |
| 2020 | 2.51% | -49.17% |
| 2019 | 4.93% | -25.65% |
| 2018 | 6.63% | -43.94% |
| 2017 | 11.84% | -3.19% |
| 2016 | 12.22% | 0.59% |
Nippon Chemiphar Co., Ltd. (4539.T) Average ROE
How has 4539.T ROE performed in the past?
The current ROE of Nippon Chemiphar Co., Ltd. (4539.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.80%
5-year avg
1.78%
10-year avg
4.71%
Nippon Chemiphar Co., Ltd. (4539.T) ROE vs. Peers
How is 4539.T’s ROE compared to its peers?
Nippon Chemiphar Co., Ltd.’s ROE is greater than Modalis Therapeutics Corporation (-64.65%), less than WDB coco Co., Ltd. (17.26%), greater than SymBio Pharmaceuticals Limited (-156.87%), greater than Cyfuse Biomedical K.K. (-33.39%), greater than MedRx Co., Ltd (-63.42%), less than Cosmo Bio Company,Limited (2.70%), less than ASO International, Inc. (16.54%), less than Shigematsu Works Co., Ltd. (6.61%), less than LEOCLAN Co.,Ltd. (2.71%), greater than Pharmarise Holdings Corporation (-3.71%),
| Company | ROE | Market cap |
|---|---|---|
| -64.65% | $4.00B | |
| 17.26% | $6.43B | |
| -156.87% | $4.54B | |
| -33.39% | $4.97B | |
| -63.42% | $6.24B | |
| 2.70% | $7.62B | |
| 16.54% | $7.04B | |
| 6.61% | $5.55B | |
| 2.71% | $5.83B | |
| -3.71% | $6.02B |
Build a custom stock screener for Nippon Chemiphar Co., Ltd. (4539.T) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nippon Chemiphar Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Nippon Chemiphar Co., Ltd. (4539.T) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Nippon Chemiphar Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Nippon Chemiphar Co., Ltd.'s ROE?
How is the ROE calculated for Nippon Chemiphar Co., Ltd. (4539.T)?
What is the highest ROE for Nippon Chemiphar Co., Ltd. (4539.T)?
What is the 3-year average ROE for Nippon Chemiphar Co., Ltd. (4539.T)?
What is the 5-year average ROE for Nippon Chemiphar Co., Ltd. (4539.T)?
How does the current ROE for Nippon Chemiphar Co., Ltd. (4539.T) compare to its historical average?